These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7568552)

  • 41. S-adenosyl methionine (SAMe) augmentation in major depressive disorder.
    Nelson JC
    Am J Psychiatry; 2010 Aug; 167(8):889-91. PubMed ID: 20693465
    [No Abstract]   [Full Text] [Related]  

  • 42. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG; Post RM
    Arch Gen Psychiatry; 1989 Sep; 46(9):794-800. PubMed ID: 2505730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible augmentation of antidepressant response by buspirone.
    Jacobsen FM
    J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is diazepam an antidepressant?
    Tiller JW; Schweitzer I; Maguire KP; Davis B
    Br J Psychiatry; 1989 Oct; 155():483-9. PubMed ID: 2692764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venlafaxine in depressed outpatients.
    Khan A; Fabre LF; Rudolph R
    Psychopharmacol Bull; 1991; 27(2):141-4. PubMed ID: 1924660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-adenosylmethionine blood levels in major depression: changes with drug treatment.
    Bell KM; Potkin SG; Carreon D; Plon L
    Acta Neurol Scand Suppl; 1994; 154():15-8. PubMed ID: 7941961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
    Amsterdam JD; Dunner DL; Fabre LF; Kiev A; Rush AJ; Goodman LI
    Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 54. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 56. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Untreated depression and hippocampal volume loss.
    Sheline YI; Gado MH; Kraemer HC
    Am J Psychiatry; 2003 Aug; 160(8):1516-8. PubMed ID: 12900317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
    Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.